anti-human CD69 no azide, Clone FN50

Description
CD69 (C-type lectin domain family 2 C, CLEC2C, also known as AIM) is one of the earliest inducible cell surface molecules acquired during leukocyte activation. This glycoprotein serves as a lectin-type receptor in lymphocytes, NK cells and platelets; it is involved in lymphocyte proliferation. CD69 expression is counteracted on T cells in the AIDS stage of HIV infection, and may be also predictive for clinical response to chemoimmunotherapy.

Properties
The monoclonal antibody ADG5079/L (clone FN50) is a murine monoclonal antibody, subclass IgG₁ kappa. The antibody has been purified from cell culture supernatant using ion exchange chromatography, Purity > 95% (by SDS-PAGE).

The antibody recognizes the CD69 antigen, an early activation marker (within 2h) on T, B and NK-cells, possibly involved in signal transduction. It is also expressed by activated platelets. On flow cytometry the antibody stains > 90% of activated human peripheral blood lymphocytes. This antibody has been studied at the 4. International Workshop on Human Leucocyte Differentiation Antigens.

Presentation
Vial containing 100 µg /100 µl (ADG5079) or 300 µg/300 µl (ADG5079L) of purified antibody in PBS (sterile) pH 7.2. The IgG concentration is 1 mg/ml. Spin the vial briefly before opening.

Storage and Stability
Store the antibody at -20°C. It is recommended to avoid freeze-thaw cycles. Should be handled under aseptic conditions. The reagent is stable until the expiry date stated on the vial label.

Applications
Functional studies.

Category: Research use only

Type: Antibody

Product Availability: Worldwide

Manufacturer: ImmBioMed GmbH & Co KG, Germany

For more information please click .pdf icon below.